Learn
Semaglutide
Orion Peptides | Research Compound Library
Semaglutide is a synthetic, lipid-modified peptide composed of 31 amino acid residues. Its molecular structure is based on glucagon-like peptide-1 (GLP-1), with selected chemical modifications that influence receptor recognition, enzyme resistance, and interactions with albumin.
The compound is identified by CAS number 910463-68-2 and has the molecular formula C₁₈₇H₂₉₁N₄₅O₅₉.
Semaglutide belongs to the class of GLP-1 receptor agonists. Its molecular architecture includes an alpha-aminoisobutyric acid substitution, an arginine substitution, and a C18 fatty diacid attached through a linker to a lysine side chain.
These modifications distinguish Semaglutide from natural GLP-1 while preserving its ability to activate the GLP-1 receptor.
In laboratory research, Semaglutide is characterized through peptide sequence analysis, receptor-binding experiments, chromatographic separation, mass spectrometry, and physicochemical testing.
This reference covers the compound’s chemical identity, structural design, receptor pharmacology, analytical characterization, and stability-related properties.
1. How Semaglutide Was Engineered from GLP-1
Semaglutide was developed from the 31-residue GLP-1(7–37) peptide sequence.
The original peptide served as a molecular template for designing an analog with modified stability and protein-binding characteristics.
Researchers retained most of the native sequence while introducing two amino acid substitutions and one lipid-containing side chain.
The resulting molecule has approximately 94% sequence identity with GLP-1(7–37) across its peptide backbone.
Three Structural Modifications That Define Semaglutide
Aib substitution at GLP-1 position 8
Natural GLP-1 contains alanine at this position.
In Semaglutide, alanine is replaced by alpha-aminoisobutyric acid, abbreviated Aib.
This modification reduces susceptibility to cleavage by dipeptidyl peptidase-4 (DPP-4).
Arginine substitution at position 34
The lysine residue normally present at GLP-1 position 34 is replaced with arginine.
This leaves lysine-26 available as the intended fatty-acid attachment site.
C18 fatty diacid conjugation
A C18 fatty diacid is attached to lysine-26 through a linker containing gamma-glutamic acid and hydrophilic spacer units.
This modification increases affinity for albumin and influences the physicochemical properties of the molecule.
Why These Modifications Matter
Peptide engineering often involves balancing multiple molecular characteristics.
A modification that increases stability may also change receptor binding or solubility.
Likewise, a lipid-containing side chain may increase protein association while influencing molecular behavior in aqueous environments.
Semaglutide illustrates how several modifications can be combined while retaining GLP-1 receptor agonist activity.
The original molecular development study described the relationship between the fatty acid structure, linker chemistry, albumin affinity, and receptor potency.
2. Semaglutide Chemical Identity
| Chemical property | Reference information |
|---|---|
| Compound name | Semaglutide |
| CAS registry number | 910463-68-2 |
| PubChem CID | 56843331 |
| Molecular formula | C₁₈₇H₂₉₁N₄₅O₅₉ |
| Molecular weight | Approximately 4,113.58 g/mol |
| Amino acid count | 31 residues |
| Structural origin | GLP-1(7–37) analog |
| Compound classification | Synthetic lipidated peptide |
| Structural configuration | Linear peptide backbone with a lipid side chain |
| Nonstandard residue | Alpha-aminoisobutyric acid (Aib) |
| Lipid modification | C18 fatty diacid |
| Conjugation site | Lysine-26 in GLP-1 numbering |
| Receptor target | GLP-1R |
| Receptor family | Class B G protein-coupled receptors |
| C-terminal group | Free carboxylic acid |
These values refer to the defined Semaglutide molecular structure.
The reported chemical characteristics of an individual research sample may also depend on counterions, residual moisture, and other material-specific properties.
Purity and physical form should be established from batch-specific analytical documentation rather than treated as universal properties of the molecule.
3. Reading the Semaglutide Amino Acid Sequence
A peptide sequence describes the order of its amino acid residues.
Semaglutide retains the general structure of GLP-1(7–37), but its sequence contains a nonstandard amino acid and a chemically modified lysine.
Semaglutide Sequence
The modified 31-residue backbone can be represented as:
His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly
The lysine residue carries the C18 fatty diacid conjugate through the defined linker.
The terminal glycine ends with a free carboxylic acid.
Understanding Amino Acid Numbering
Semaglutide literature commonly uses GLP-1 numbering rather than numbering the shortened 31-residue chain from one.
This creates two valid ways to describe selected positions.
| Structural feature | GLP-1 numbering | Position within 31-residue chain |
|---|---|---|
| Aib substitution | 8 | 2 |
| Fatty acid attachment | 26 | 20 |
| Arginine substitution | 34 | 28 |
Both numbering systems describe the same positions.
However, using them interchangeably without explanation can cause confusion when comparing peptide sequences or analytical records.
What Does Aib Mean in a Sequence?
Aib stands for alpha-aminoisobutyric acid.
It is not one of the 20 standard proteinogenic amino acids.
Some sequence databases represent nonstandard residues using a placeholder such as X.
Therefore, a one-letter sequence containing X should be interpreted alongside an explanation of the corresponding chemical modification.
4. The Role of the C18 Fatty Diacid
Semaglutide contains a C18 fatty diacid attached to its peptide backbone.
This modification contributes a lipophilic region to an otherwise highly polar molecule.
The resulting structure is amphiphilic.
An amphiphilic molecule contains regions with different interactions toward polar and relatively nonpolar environments.
What Is Fatty Acid Conjugation?
Fatty acid conjugation is the covalent attachment of a lipid-containing group to another molecule.
In peptide chemistry, lipidation can influence protein binding, solubility, molecular association, and pharmacokinetic characteristics.
The exact behavior depends on the fatty acid, linker structure, and peptide backbone.
Why Is a Linker Necessary?
A linker separates the fatty acid from the peptide backbone.
Its structure can influence how the lipid-containing group interacts with the peptide and surrounding molecules.
Semaglutide incorporates a linker containing gamma-glutamic acid and two hydrophilic spacer units.
This arrangement was selected during molecular optimization to balance albumin affinity with GLP-1 receptor activity.
Semaglutide and Albumin Binding
Albumin is a protein capable of binding several classes of molecules, including fatty acids.
The C18 fatty diacid promotes reversible interactions between Semaglutide and albumin.
The molecular interaction influences the behavior of the peptide in biological systems.
The original discovery study found that increasing albumin affinity was an important part of Semaglutide’s molecular design.
Is Albumin Binding the Same as Receptor Binding?
No.
Albumin binding and GLP-1 receptor binding are different molecular interactions.
Albumin association affects how a peptide interacts with a carrier protein.
GLP-1 receptor binding produces a receptor-mediated signaling response.
These properties must be evaluated using different experimental methods.
5. How Does Semaglutide Interact with GLP-1 Receptors?
Semaglutide acts as an agonist at the GLP-1 receptor.
GLP-1R belongs to the class B family of G protein-coupled receptors.
These receptors contain a transmembrane region and an extracellular domain involved in ligand recognition.
Ligand Recognition
A ligand is a molecule that binds to a specific molecular target.
Semaglutide is a ligand for GLP-1R.
The peptide’s amino acid sequence contains structural features that support receptor recognition.
Binding helps stabilize an active receptor conformation.
Receptor Activation
Once the receptor is activated, it can communicate with intracellular signaling proteins.
One important signaling route involves Gs proteins and adenylyl cyclase.
Adenylyl cyclase generates cyclic adenosine monophosphate, or cAMP.
cAMP functions as a second messenger within cells.
Measuring GLP-1R Activity
Researchers can investigate GLP-1R activity using cell-based receptor assays.
A concentration-response experiment measures the relationship between ligand concentration and a selected cellular signal.
Common experimental parameters include:
| Parameter | Meaning |
|---|---|
| Binding affinity | Strength of molecular association with the receptor |
| EC50 | Concentration associated with half-maximal measured response |
| Emax | Maximum observed response under assay conditions |
| cAMP response | Intracellular signaling measurement |
| Receptor internalization | Movement of receptors from the cell surface |
| Beta-arrestin recruitment | Interaction with proteins involved in GPCR regulation |
These measurements characterize receptor pharmacology.
They are not interchangeable, and their values depend on the experimental systems used.
6. What the Original Semaglutide Research Established
Semaglutide’s molecular design was described in a 2015 paper published in the Journal of Medicinal Chemistry.
The researchers examined how fatty acid modification and linker structure influenced molecular properties.
The study compared several GLP-1 analogs before selecting Semaglutide as a candidate for further investigation.
Receptor Affinity
The researchers reported GLP-1 receptor affinity of approximately 0.38 ± 0.06 nM for Semaglutide under their experimental conditions.
This measurement described its interaction with the receptor in the specific assay system.
Albumin Affinity
The study found that Semaglutide had increased albumin affinity compared with an earlier lipidated GLP-1 analog, liraglutide.
The authors attributed the difference partly to the fatty acid and linker architecture.
Structure-Activity Relationships
The study demonstrated that molecular modifications can influence several properties at once.
A peptide’s receptor affinity, albumin binding, and metabolic stability may respond differently to changes in chemical structure.
This is why researchers evaluate multiple properties during peptide optimization.
Primary research: Lau J. et al. (2015), Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.
https://doi.org/10.1021/acs.jmedchem.5b00726
7. Semaglutide’s Physicochemical Characteristics
Chemical identity alone does not describe how a peptide behaves under every laboratory condition.
Semaglutide contains polar amino acid residues, ionizable functional groups, and a lipid-containing side chain.
These features influence its interactions with solvents and surfaces.
Charge and Ionization
Some amino acid side chains contain chemical groups that can gain or lose protons.
Their ionization state depends on the surrounding pH.
Changes in ionization can influence solubility and interactions with other molecules.
Solubility Behavior
Semaglutide’s solubility depends on the experimental environment.
Relevant variables include pH, ionic strength, concentration, temperature, and formulation composition.
A solubility statement is most useful when it identifies the tested conditions.
Interaction with Laboratory Surfaces
Peptides may adsorb onto glass, plastic, and other materials.
Adsorption can influence analytical recovery and measured concentrations.
Lipidated peptides may present additional considerations because of their hydrophobic regions.
Aggregation and Molecular Association
Some peptides can associate into larger molecular assemblies.
The extent of association depends on molecular characteristics and the surrounding conditions.
A sample that appears clear may still contain soluble aggregates.
Physical appearance alone is not sufficient to determine molecular association.
8. Analytical Identification: Beyond a Molecular Weight Number
A molecular formula provides the theoretical elemental composition of a compound.
However, identifying a complex peptide requires more than comparing one numerical mass value.
Semaglutide contains nonstandard structural features that must be accounted for during analysis.
Mass Spectrometry
Mass spectrometry measures the mass-to-charge ratios of ionized molecules.
Electrospray ionization mass spectrometry is commonly used to characterize large synthetic peptides.
The analysis may produce several charge states.
These signals can be processed to estimate molecular mass.
A result consistent with the expected Semaglutide mass provides useful identity-related evidence.
However, mass agreement alone does not verify every amino acid position or structural feature.
High-Performance Liquid Chromatography
HPLC separates components within a sample.
Reversed-phase HPLC is commonly used in peptide analysis.
It can reveal chromatographic peaks associated with the main component and certain impurities.
The reported purity depends on the analytical method, detection system, and integration approach.
Liquid Chromatography-Mass Spectrometry
LC-MS combines chromatographic separation with mass analysis.
This approach allows researchers to evaluate mass-related information for different components separated during chromatography.
It may help characterize some peptide-related impurities.
Why Complementary Methods Are Important
Different analytical techniques answer different questions.
| Analytical method | Primary information |
|---|---|
| RP-HPLC | Chromatographic purity and separation |
| Mass spectrometry | Molecular mass |
| LC-MS | Mass information for chromatographically separated components |
| LC-MS/MS | Additional sequence or structural evidence |
| Peptide content assay | Amount of peptide under a specified method |
| Water-content analysis | Moisture information |
| Stability-indicating chromatography | Changes during defined observation periods |
A combination of methods can provide a more complete analytical picture than one result alone.
9. How to Interpret a Semaglutide COA
A Certificate of Analysis is a record of analytical testing performed on a specified sample or batch.
For a chemically modified peptide, the report should clearly connect the measured results to the identified material.
Important COA Fields
| Field | Technical significance |
|---|---|
| Sample name | Identifies the material tested |
| Batch number | Links results to a particular lot |
| Expected molecular mass | Reference for mass spectrometric comparison |
| HPLC chromatogram | Displays chromatographic separation |
| HPLC purity | Reports the result under the specified method |
| MS data | Provides molecular mass-related evidence |
| Peptide content | Measures content when separately tested |
| Water content | Reports moisture if analyzed |
| Testing date | Documents timing of analysis |
| Analytical methods | Describes how results were obtained |
| Laboratory identification | Identifies the testing organization |
Is HPLC Purity the Same as Peptide Content?
No.
HPLC purity often refers to relative peak-area measurements.
Peptide content describes the amount of peptide present in a material.
A sample can have high chromatographic purity while still containing residual water, counterions, or other substances not represented by the chromatographic percentage.
Can a Single COA Verify Every Batch?
No.
A COA is associated with the sample or batch examined.
Results for one material should not automatically be assigned to separate production batches.
Why Does Structural Identity Matter?
Different molecules may have similar molecular masses.
A mass measurement consistent with Semaglutide is therefore an important part of identity testing, but additional evidence may be necessary to establish the full molecular structure.
10. Semaglutide Stability and Degradation Research
Peptide stability refers to the retention of defined chemical and physical characteristics over time under specified conditions.
Semaglutide contains a chemically modified peptide backbone and a lipid-containing side chain.
These structural features should be considered when interpreting stability research.
Chemical Degradation
Potential peptide degradation processes may include hydrolysis, oxidation, and reactions involving susceptible amino acid residues.
Their occurrence and rate depend on the formulation and environmental conditions.
Physical Stability
Physical changes may include aggregation, adsorption, or changes in molecular association.
These can occur without necessarily changing the primary amino acid sequence.
Environmental Factors
Relevant stability variables include:
- Temperature
- Moisture
- Solution pH
- Oxygen exposure
- Light exposure
- Buffer composition
- Storage duration
Lyophilized vs Solution-State Samples
Lyophilization removes water through freeze-drying.
This can improve the stability of some peptide formulations, but it does not guarantee a particular shelf life.
A peptide in solution may exhibit different chemical and physical behavior from a lyophilized sample.
The stability characteristics of each material should be evaluated under its own defined conditions.
Does Semaglutide Have a Universal Storage Temperature?
No single storage temperature can be assumed appropriate for every Semaglutide material or formulation.
Storage requirements must be supported by stability data for the specific material being characterized.
The conditions of one formulation should not automatically be applied to another.
11. Semaglutide Compared with Related Research Peptides
Semaglutide belongs to a group of synthetic peptides designed to interact with metabolic hormone receptors.
Two relevant compounds for molecular comparison are Tirzepatide and Retatrutide.
Semaglutide and Tirzepatide
Semaglutide is derived from the GLP-1 sequence and activates GLP-1R.
Tirzepatide is derived from a GIP-related sequence and activates both GIPR and GLP-1R.
Both molecules contain fatty-acid-based modifications, but they differ in peptide length and chemical architecture.
Semaglutide and Retatrutide
Retatrutide is a modified peptide designed to activate GIPR, GLP-1R, and GCGR.
Semaglutide is a GLP-1 receptor agonist.
Their receptor target profiles are therefore different.
Molecular Comparison
| Characteristic | Semaglutide | Tirzepatide | Retatrutide |
|---|---|---|---|
| Amino acid residues | 31 | 39 | 39 |
| Peptide backbone | GLP-1-derived | GIP-derived | GIP-derived |
| GLP-1R activity | Yes | Yes | Yes |
| GIPR activity | No | Yes | Yes |
| GCGR activity | No | No | Yes |
| Fatty-acid modification | C18 | C20 | C20 |
| Structural classification | Lipidated peptide | Lipidated peptide | Lipidated peptide |
This comparison concerns molecular architecture and receptor activity only.
12. Frequently Asked Technical Questions
What is Semaglutide?
Semaglutide is a synthetic 31-amino-acid peptide derived from GLP-1 and chemically modified with a C18 fatty diacid side chain.
What is the molecular formula of Semaglutide?
C₁₈₇H₂₉₁N₄₅O₅₉.
What is Semaglutide’s molecular weight?
Approximately 4,113.58 g/mol.
What is the CAS number of Semaglutide?
910463-68-2.
How many amino acids are in Semaglutide?
Semaglutide has 31 amino acid residues.
Is Semaglutide a linear peptide?
It has a linear peptide backbone with a conjugated lipid-containing side chain.
What natural peptide is Semaglutide based on?
Semaglutide is based on GLP-1(7–37).
What is Aib in Semaglutide?
Aib is alpha-aminoisobutyric acid, a nonstandard amino acid introduced at GLP-1 position 8.
Why does Semaglutide contain arginine at position 34?
The substitution helps leave lysine-26 as the defined site for fatty-acid conjugation.
What is attached to lysine-26?
A C18 fatty diacid connected through a linker containing gamma-glutamic acid and hydrophilic spacer units.
What does lipidation mean?
Lipidation is the chemical attachment of a lipid-containing group to another molecule.
What receptor does Semaglutide activate?
Semaglutide activates GLP-1R.
Is Semaglutide a dual receptor agonist?
No. Semaglutide is classified as a GLP-1 receptor agonist.
What is the difference between Semaglutide and Tirzepatide?
Semaglutide activates GLP-1R, while Tirzepatide activates GIPR and GLP-1R.
What is the difference between Semaglutide and Retatrutide?
Retatrutide activates GIPR, GLP-1R, and GCGR, while Semaglutide activates GLP-1R.
What does HPLC reveal about Semaglutide?
HPLC can provide information about chromatographic purity and separation of certain impurities.
Does HPLC measure molecular weight?
No. Molecular mass is typically assessed through mass spectrometry.
What is a Semaglutide COA?
A COA documents specified analytical tests and results for an identified sample or batch.
Is 99% HPLC purity the same as 99% peptide content?
No. These are different analytical measurements.
Can Semaglutide undergo chemical degradation?
Yes. Chemical stability depends on structure, formulation, and environmental conditions.
Can mass spectrometry establish complete sequence identity?
Not necessarily. A matching molecular mass does not uniquely establish every structural feature.
13. Scientific References and Chemical Resources
Primary Molecular Development Study
Lau J. et al. (2015)
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.
Journal: Journal of Medicinal Chemistry, 58(18), 7370–7380.
Research relevance: Amino acid substitutions, fatty acid conjugation, linker chemistry, GLP-1 receptor affinity, and molecular optimization.
https://doi.org/10.1021/acs.jmedchem.5b00726
PubChem Chemical Reference
Semaglutide — PubChem CID 56843331
Reference information: Molecular formula, chemical structure, molecular weight, synonyms, and identifiers.
https://pubchem.ncbi.nlm.nih.gov/compound/56843331
KEGG Chemical Reference
Semaglutide — KEGG D10025
Reference information: Compound identifiers, molecular formula, and structural data.
https://www.kegg.jp/entry/D10025
IUPHAR/BPS Guide to Pharmacology
GLP-1 Receptor
Reference information: Receptor classification, ligand interactions, and pharmacological terminology.
https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=249
Conclusion
Semaglutide illustrates how selective chemical modifications can change the properties of a naturally derived peptide sequence.
Its 31-residue GLP-1-based backbone contains an Aib substitution, an arginine substitution, and a C18 fatty diacid conjugate attached to lysine-26.
These structural features influence enzymatic stability, albumin interaction, and the molecular characteristics of the compound while preserving GLP-1 receptor activity.
For technical research, Semaglutide is evaluated through molecular identity testing, receptor assays, chromatographic methods, and stability-related analysis.
Understanding the distinction between theoretical chemical properties and measured batch-specific results is essential for accurate scientific characterization.
Technical reference notice: This educational resource focuses on Semaglutide chemistry, receptor pharmacology, and analytical research. It contains no dosing or administration guidance. Analytical documentation for a research material does not establish equivalence to any regulated pharmaceutical formulation.
